Cancer Management Using Photodynamic Therapy: Fundamentals, Mechanism and Advances.

IF 2.8 4区 医学 Q2 PHARMACOLOGY & PHARMACY
Mitul Lovras, Shivam Rajput, Sathvik Belagodu Sridhar, Javedh Shareef, Rishabha Malviya
{"title":"Cancer Management Using Photodynamic Therapy: Fundamentals, Mechanism and Advances.","authors":"Mitul Lovras, Shivam Rajput, Sathvik Belagodu Sridhar, Javedh Shareef, Rishabha Malviya","doi":"10.2174/0113816128364893250603035546","DOIUrl":null,"url":null,"abstract":"<p><p>PDT is a common and minimally invasive treatment used for certain types of cancer. Photodynamic therapy involves the generation of reactive oxygen species, resulting in cellular apoptosis and disruption of the tumor microenvironment. This review presents a comprehensive examination of recent developments in Photodynamic Therapy (PDT), detailing its mechanisms, the importance of photosensitizers, and their applications across various cancer types. Photosensitizers are essential in photodynamic therapy as they generate reactive oxygen species when exposed to light. Advanced photosensitizers demonstrate high conversion efficiency, improved tumor specificity, and reduced adverse effects. Recent advancements have led to the creation of photosensitizers that exhibit enhanced solubility, stability, and the ability to selectively accumulate in tumors. Combination therapies that incorporate PDT exhibit notable therapeutic outcomes, indicating substantial progress in the field. Recent developments in photodynamic therapy, particularly those that boost immune responses, show considerable promise in significantly enhancing the effectiveness of tumor elimination. These advancements have the potential to enhance the therapeutic application of photodynamic therapy, offering new possibilities for cancer treatment.</p>","PeriodicalId":10845,"journal":{"name":"Current pharmaceutical design","volume":" ","pages":""},"PeriodicalIF":2.8000,"publicationDate":"2025-06-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Current pharmaceutical design","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.2174/0113816128364893250603035546","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"PHARMACOLOGY & PHARMACY","Score":null,"Total":0}
引用次数: 0

Abstract

PDT is a common and minimally invasive treatment used for certain types of cancer. Photodynamic therapy involves the generation of reactive oxygen species, resulting in cellular apoptosis and disruption of the tumor microenvironment. This review presents a comprehensive examination of recent developments in Photodynamic Therapy (PDT), detailing its mechanisms, the importance of photosensitizers, and their applications across various cancer types. Photosensitizers are essential in photodynamic therapy as they generate reactive oxygen species when exposed to light. Advanced photosensitizers demonstrate high conversion efficiency, improved tumor specificity, and reduced adverse effects. Recent advancements have led to the creation of photosensitizers that exhibit enhanced solubility, stability, and the ability to selectively accumulate in tumors. Combination therapies that incorporate PDT exhibit notable therapeutic outcomes, indicating substantial progress in the field. Recent developments in photodynamic therapy, particularly those that boost immune responses, show considerable promise in significantly enhancing the effectiveness of tumor elimination. These advancements have the potential to enhance the therapeutic application of photodynamic therapy, offering new possibilities for cancer treatment.

利用光动力疗法治疗癌症:基础、机制和进展。
PDT是一种常见的微创治疗方法,用于治疗某些类型的癌症。光动力疗法涉及活性氧的产生,导致细胞凋亡和肿瘤微环境的破坏。本文综述了光动力疗法(PDT)的最新进展,详细介绍了其机制、光敏剂的重要性及其在各种癌症类型中的应用。光敏剂在光动力治疗中是必不可少的,因为它们在暴露于光下时会产生活性氧。先进的光敏剂具有高转化效率、提高肿瘤特异性和减少不良反应的特点。最近的进展导致了光敏剂的产生,这些光敏剂表现出增强的溶解度、稳定性和在肿瘤中选择性积累的能力。结合PDT的联合疗法表现出显著的治疗效果,表明该领域取得了实质性进展。光动力疗法的最新进展,特别是那些增强免疫反应的疗法,在显著提高肿瘤消除的有效性方面显示出相当大的希望。这些进展有可能增强光动力疗法的治疗应用,为癌症治疗提供新的可能性。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
6.30
自引率
0.00%
发文量
302
审稿时长
2 months
期刊介绍: Current Pharmaceutical Design publishes timely in-depth reviews and research articles from leading pharmaceutical researchers in the field, covering all aspects of current research in rational drug design. Each issue is devoted to a single major therapeutic area guest edited by an acknowledged authority in the field. Each thematic issue of Current Pharmaceutical Design covers all subject areas of major importance to modern drug design including: medicinal chemistry, pharmacology, drug targets and disease mechanism.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信